News Feeds

Bio Screening Industry News

Selected Bio Screening news, events and internet recources.

InhibOx and the National Foundation for Cancer Research Announce Launch of DrugFinder Oxford, UK (OBBeC) - InhibOx has announced the launch of a free hit identification service. This new service, according to the announcement, will enable research groups in academia and biotechnology companies to exploit an increasingly important starting point for novel drug discovery, namely, crystal structures of target proteins with an inhibitor bound in the active [...] Sanofi-aventis signs a collaboration agreement with RainDance Technologies and Louis Pasteur Univers The FINANCIAL — Sanofi-aventis announced on September 26 the launch of the dScreen Consortium, a research initiative conducted with RainDance Technologies, Inc., Lexington, Massachusetts, and Louis Pasteur University, Strasbourg, France, to develop the next generation of High-Throughput Screening (HTS) for drug discovery applications. The consortium was founded with the assistance of the Alsace BioValleyTM Cluster, France, which helped [...] deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer Detection may be used to complement and target screening for the disease; findings will be integrated into the deCODEme(TM) personal genome scan. Last update: 1:30 p.m. EDT Sept. 14, 2008 REYKJAVIK, Iceland, Sept 14, 2008 DCGN and colleagues at Radboud University Medical Center in the Netherlands today report the discovery of two common single-letter variants in the human [...] Colon Cancer Oncogene Discovered SUNDAY, Sept. 14 (HealthDay News) — Researchers have identified a new genetic player in the development of colon cancer. The findings implicate CDK8, a protein that regulates gene expression in the proliferation of colorectal cancer, the researchers found. Should the results be validated, they could lead to new therapeutic approaches for colon cancer, as well as new [...] BioServe Introduces Customizable DNA Panels for Genetic Research BELTSVILLE, MD — September 11, 2008 — BioServe today announced a more affordable pricing plan for its vast bank of DNA with comprehensive, de-identified, covariate data that includes age, gender, diet, body mass index (BMI), and race. In addition, each sample has data on the complete diagnostic and treatment history of the donor. BioServe’s DNA [...] First of 100 Arab Human Genomes Sequenced by Saudi Biosciences, Beijing Genomics Institute Shenzhen, and CLC bio Riyadh, Kingdom of Saudi Arabia — September 9, 2008 — An international consortium consisting of Saudi Biosciences, Beijing Genomics Institute Shenzhen, and CLC bio have in a joint effort performed an initial sequencing and analysis of the first Arab human genome, as part of a large project to sequence 100 Arab [...] TOCRIS SIGNS EXCLUSIVE DEAL TO SUPPLY GEFITINIB September 4th, 2008 - Tocris Bioscience announced today the signing of an exclusive deal with AstraZeneca to supply Gefitinib (also known as Iressa  and ZD1839) to preclinical researchers working on the mechanisms underlying cancer development. For the first time, scientists will be able to buy authentic, fully licensed, non-formulated Gefitinib as an off-the shelf product [...] BIO-Europe 2008: The World?s Leading Biotech Companies and Deal-Makers Get Ready for Three Days of Intense Partnering in Mannheim/Heidelberg CARLSBAD, Calif. & WASHINGTON — September 2, 2008 — The leaders of the biotechnology industry will once again gather for BIO-Europe, the world’s largest stand-alone partnering conference, in Mannheim/Heidelberg, Germany, November 17-19. With biotech deal-making still the thrill in drug development markets, this year’s BIO-Europe promises to set new standards for generating quality partnering meetings [...] New drug slows down cancer WA researchers have taken the first step towards developing new anti-cancer medications that could activate a gene shown to block the growth of cancerous cells. Led by Western Australian Institute for Medical Research (WAIMR) Director Professor Peter Klinken, the scientists have screened a large collection of drug-like molecules and recently identified a number of compounds which [...] AstraZeneca, Singapore institutions sign innovative new partnership to develop anti-cancer compounds Healthcare company AstraZeneca Plc (AZN: News, Chart, Quote ,AZN.L: News, Chart, Quote ) said Friday that it signed an innovative new partnership with the National Cancer Centre Singapore, or NCCS, and the National University Hospital, or NUH, for development of anti-cancer compounds. The [...] Pharma Invests Big in Stem Cells GSK gives the Harvard Stem Cell Institute $25 million. Today, the pharma company GlaxoSmithKline (GSK) announced a five-year, $25-million-plus collaborative agreement with the Harvard Stem Cell Institute to develop new methods for screening drugs with stem cells. “GSK believes stem cell science has great potential to aid the discovery of new medicines by improving the screening, identification, [...] CLC bio release white paper on the world?s fastest Next Generation Sequencing assembly algorithm Aarhus Denmark — July 23, 2008 — CLC bio has just released a scientific white paper which confirms, that, in benchmarking tests, CLC bio?s new algorithm for assembly of Next Generation Sequencing data is the fastest one available. Not only is CLC bio?s algorithm considerably faster, but it also provides a [...] BioPharm America Unveils Conference Program First Stand-Alone Partnering Conference Held in the USA to Attract the Biggest Names in Global Biotech for Two Days of Intense Networking Carlsbad, CA. and Atlanta, GA., July 24, 2008: With only two months until the start of BioPharm America(TM) in Atlanta, September 9-10, 2008, EBD Group today announced the conference’s program [...] AgriGenomics World Congress 2008 29-30 September 2008, Amsterdam, The Netherlands Select Biosciences is proud to announce their inaugural AgriGenomics World Congress. This year’s event will take place at the NH Grand Hotel Krasnapolsky in Amsterdam. AgriGenomics.eu Alongside an exhibition of selected scientific posters and service providers, Select Biosciences is organizing a two day event gathering some of the most influential players in the [...] Seegene and Shimadzu Agree to Join Multi-Pathogen Tests and Platform for Combined Analytics Solution ROCKVILLE, MD and KYOTO, JAPAN–July 28, 2008 - Seegene, Inc. and Shimadzu Corporation today announced a strategic partnership to combine Seegene’s Seeplex(R) multi-pathogen tests with Shimadzu’s MultiNA (1) analytical platform. Under terms of the deal, Shimadzu and Seegene will collaborate on integrating the Seeplex polymerase chain reaction-based tests with Shimadzu’s [...] Why Genentech will say ?yes? to Roche The biotech firm faces burdens that come with age, and the Swiss drug maker looks like a good partner. NEW YORK (Fortune) — As Genentech’s board weighs Monday’s $43.7 billion merger proposal from Roche, the South San Francisco biotech has one overarching reason to fall deeper into the arms of the Swiss drug maker that already [...] Genentech confirms buyout offer from Roche; shares rally NEW YORK (Thomson Financial) - Shares of Genentech Inc. surged to their highest price in more than two years on Monday after the San Francisco-based biotechnology company confirmed its receipt of a buyout offer from Roche. The shares jumped 14% to $93.09 on Monday on a volume of 8 million shares. The issue’s 30-day volume is [...] Roche Wants to Buy Genentech ? Again In what could become one of the biggest biotech deals ever, Roche announced this morning that it was offering to pay $43.7 billion for the remaining Genentech (NYSE: DNA) shares it doesn’t already own. Roche and Genentech have had a long and complicated relationship since the 1980s, after Genentech outlicensed one of its first [...] 2nd annual Biosimilars Conference September 10 - 11, Berlin, Germany The future of the pharmaceutical industry lies with biotechnology. Biotech drugs account for around 10-15% of the current pharmaceutical market, and the sector is outperforming the market as a whole in terms of growth. With increasing regulatory clarity and the expiries of key patents covering innovator biologics, the development of biosimilars for a range of [...] Improving Solubility 2008 October 27-29, 2008 Philadelphia, PA This year?s Improving Solubility conference is essential for scientists working with poorly soluble drugs. With the increased number of poorly soluble drugs coming to the market, expansion of pipelines, effective research investment, and the incorporation of the correct strategy, it is vital for scientists working with poorly soluble drugs to ensure that they have the [...]